Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: A novel Boswellia serrata extract

Molecular and Cellular Biochemistry

Volumn 354, Issue 1-2, 2011, Pages 189-197

  Sengupta, Krishanu ^a   Kolla, Jayaprakash N ^a   Krishnaraju, Alluri V ^a   Yalamanchili, Nandini ^a   Rao, Chirravuri V ^a   Golakoti, Trimurtulu ^a   Raychaudhuri, Smriti ^b   Raychaudhuri, Siba P ^b  

^a Laila Impex R and D Centre   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 O acetyl 11 keto boswellic acid; Aflapin; Boswellia serrata; Chondrocytes; Matrix metalloproteinase 3; Osteoarthritis

Indexed keywords

3 O ACETYL 11 KETO BETA BOSWELLIC ACID; 5 LOXIN; AFLAPIN; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; FREUND ADJUVANT; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BOSWELLIA SERRATA; CARTILAGE CELL; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BIOAVAILABILITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; MEDICINAL PLANT; MOLECULAR BIOLOGY; NONHUMAN; OSTEOARTHRITIS; PROTEIN DEGRADATION; RAT; RHEUMATOID ARTHRITIS; SPRAGUE DAWLEY RAT; SYNOVIOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; BIOLOGICAL AVAILABILITY; BOSWELLIA; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FOOT; FREUND'S ADJUVANT; GLYCOSAMINOGLYCANS; HINDLIMB; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LIPOXYGENASE INHIBITORS; MALE; MATRIX METALLOPROTEINASE 3; OSTEOARTHRITIS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BOSWELLIA; BOSWELLIA SERRATA; RATTUS;

EID: 79959777940     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0818-1     Document Type: Article

References (39)

1. Reddy GK, Chandrasekhar G, Dhar SC (1989) Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem Pharmacol 38:3527-3534
2. Safayhi H, Mack T, Sabiera J, Anazodo MI, Subramanian LR, Ammon HP (1992) Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261:1143-1146
3. Ammon HP, Safayhi H, Mack T, Sabieraj J (1993) Mechanism of anti-inflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 38:113-119 (Pubitemid 23136055)
4. Safayhi H, Sailer ER, Ammon HP (1995) Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol 47:1212-1216
5. Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, Safayhi H (1996) Acetyl-11-keto-beta-boswellic acid: structure requirement for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol 117:615-618 (Pubitemid 26070238)
6. Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, Ammon HP (1998) Effect of Boswellia serrata gum resin in patients with bronchial asthma: results of double blind, placebo controlled, 6-week clinical study. Eur J Med Res 3:511-514
7. Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, Ammon HP (2001) Effect of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 67:391-395 (Pubitemid 32652571)
8. Kimmatkar N, Thawani V, Hingorani I, Khiyani R (2003) Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-A randomized double blind placebo controlled trial. Phytomedicine 10:3-7 (Pubitemid 36262200)
9. Gokaraju G, Gokaraju R, Gottumukkala VS, Golakoti T, Pratha S. Process for producing a fraction enriched up to 100% 3-Oacetyl-11-keto-beta boswellic acid from an extract containing a mixture of boswellic acid. Indian Patent # 205269
10. Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss HG, Subbaraju GV, Trimurtulu G, Krishnaraju AV, Bagchi M, Bagchi D, Sen CK (2005) Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in micro vascular endothelial cells. DNA Cell Biol 24:244-255 (Pubitemid 40490263)
11. Roy S, Khanna S, Krishnaraju AV, Subbaraju GV, Yasmin T, Bagchi D, Sen CK (2006) Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to anti-inflammatory Boswellia. Antiox Redox Signal 3&4:653-660
12. Sengupta K, Golakoti T, Marasetti A, Tummala T, Ravada S, Krishnaraju A, Siba P, Raychaudhuri SP (2009) 30% 3-O-acetyl-11-keto-b-boswellic acid inhibits TNFa production and blocks MAPK/NFκB activation in lipopolysaccharide induced THP-1 human monocytes. J Food Lipids 16:325-344
13. Lalithakumari K, Krishnaraju AV, Sengupta K, Subbaraju GV, Chatterjee A (2006) Safety and toxicological evaluation of a novel, standardized 3-O-Acetyl-b-Boswellic Acid (AKBA)-enriched Boswellia serrata extract (5-Loxin®). Toxicol Mech Methods 16:199-226
14. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP (2008) A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthr Res Ther 10(4):R85
15. Abdel Tawab M, Kaunzinger A, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M (2001) Development of a high-performance liquid chromatographic method for the determination of 11-keto-β-boswellic acid in human plasma. J Chromatogr Biomed Appl 761:221-227 (Pubitemid 32817112)
16. Buchele B, Simmet T (2003) Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. J Chromatogr B 795:355-362 (Pubitemid 37186805)
17. Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R (2004) Pharmacokinetic study of 11-keto-β-boswellic acid. Phytomedicine 11:1255-1260
18. Sterk V, Buchele B, Simmet T (2004) Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med 70:1155-1160 (Pubitemid 40101096)
19. Kruger P, Daneshfar R, Eckert GP, Klein J, Volmer DA, Bahr U, Muller WE, Karas M, Schubert-Zsilavecz M, Abdel Tawab M (2008) Metabolism of boswellic acids in vitro and in vivo. Drug Metab Depos 36:1135-1142 (Pubitemid 351717472)
20. Lunstrum GP, Keene DR, Weksler NB, Cho YJ, Cornwall M, Horton WA (1999) Chondrocyte differentiation in a rat mesenchymal cell line. J Histochem Cytochem 47(1):1-6 (Pubitemid 29044283)
21. Tyler JA (1985) Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes decreased number of normal proteoglycan molecules. Biochem J 227:869-878
22. Benton HP, Tyler JA (1988) Inhibition of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Comm 154:421-428
23. den Berg WB, de Loo AAJ, Zwarts WA, Otterness IG (1988) Effects of murine recombinant IL-1 intact homologous articular cartilage: quantitative and autoradiographic study. Ann Rheum Dis 47:855-863
24. Jarvinen TAH, Moilanen T, Jarvinen TLN, Moilanen E (1995) Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediat Inflamm 4:107-111
25. Safayhi H, Rall B, Sailer ER, Ammon HPT (1997) Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther 281:460-463 (Pubitemid 27203102)
26. Syrovets T, Buchele B, Krauss C, Laumonnier Y, Simmet T (2005) Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-a induction in monocytes by direct interaction with IkB kinases. J Immunol 174:498-506 (Pubitemid 40007440)
27. Poeckel D, Werz O (2006) Boswellic acids: biological actions and molecular targets. Curr Med Chem 13:3359-3369 (Pubitemid 44873750)
28. Mitrovic DM, Quintero M, Stankovic A, Ruckeweart A (1983) Cell density of adult human femoral condylar articular cartilage: joints with normal and fibrillated surfaces. Lab Invest 49:309-316 (Pubitemid 13012060)
29. Bendele AM, White SL (1987) Early histopathologic and ultrastructural alterations in femorotibial joints of partial medial meniscectomized guinea pigs. Vet Pathol 24:436-443
30. Hashimoto S, Ochs RL, Komiya S, Lotz M (1998) Linkage of chondrocytes apoptosis and cartilage degradation in human osteoarthritis. Arthr Rheum 41:1632-1638 (Pubitemid 28459922)
31. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F (1998) Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthr Rheum 41:284-289 (Pubitemid 28087696)
32. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH (1991) Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147:3915-3920
33. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
34. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM (1994) A tetrazolium based colorimetric MTT assay to quantitate human monocytes mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 174:311-320
35. Benton HP, Tyler JA (1988) Inhibition of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 154:421-428
36. Martel-Pelletier J, Pelletier JP (1996) Wanted-The collagenase responsible for the destruction of the collagen network in human cartilage!. Br J Rheumatol 35:818-820
37. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C et al (1997) Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99:1534-1545 (Pubitemid 27163804)
38. Poole AR (1997) Arthritis and allied conditions. In: Koopman WJ (ed) A textbook of rheumatology. Williams and Wilkins, Baltimore, pp 255-308
39. Arend WP, Dayer JM (1990) Cytokines and cytokine inhibitors antagonists in rheumatoid arthritis. Arthr Rheum 33:305-315 (Pubitemid 20109181)